» Articles » PMID: 38235595

Evaluation of Gut Microbiota Predictive Potential Associated with Phenotypic Characteristics to Identify Multifactorial Diseases

Abstract

Design: We assessed 50 healthy and 152 unhealthy individuals for phenotypic variables (PV) and gut microbiota (GM) composition by 16S rRNA gene sequencing. The entire modeling process was conducted in the R environment using the Random Forest algorithm. Model performance was assessed through ROC curve construction.

Results: We evaluated 52 bacterial taxa and pre-selected PV ( < 0.05) for their contribution to the final models. Across all diseases, the models achieved their best performance when GM and PV data were integrated. Notably, the integrated predictive models demonstrated exceptional performance for rheumatoid arthritis (AUC = 88.03%), type 2 diabetes (AUC = 96.96%), systemic lupus erythematosus (AUC = 98.4%), and type 1 diabetes (AUC = 86.19%).

Conclusion: Our findings underscore that the selection of bacterial taxa based solely on differences in relative abundance between groups is insufficient to serve as clinical markers. Machine learning techniques are essential for mitigating the considerable variability observed within gut microbiota. In our study, the use of microbial taxa alone exhibited limited predictive power for health outcomes, while the integration of phenotypic variables into predictive models substantially enhanced their predictive capabilities.

Citing Articles

The causal relationship between the human gut microbiota and pyogenic arthritis: a Mendelian randomization study.

Bai B, Luo L, Yao F, Sun Q, Chen X, Zheng W Front Cell Infect Microbiol. 2024; 14:1452480.

PMID: 39660282 PMC: 11629706. DOI: 10.3389/fcimb.2024.1452480.


Celiac disease gut microbiome studies in the third millennium: reviewing the findings and gaps of available literature.

Luz V, Pereira S Front Med Technol. 2024; 6:1413637.

PMID: 39355139 PMC: 11444026. DOI: 10.3389/fmedt.2024.1413637.


From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?.

Vilela C, Araujo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C Cells. 2024; 13(9.

PMID: 38727306 PMC: 11083070. DOI: 10.3390/cells13090770.

References
1.
Dhaliwal J, Erdman L, Drysdale E, Rinawi F, Muir J, Walters T . Accurate Classification of Pediatric Colonic Inflammatory Bowel Disease Subtype Using a Random Forest Machine Learning Classifier. J Pediatr Gastroenterol Nutr. 2020; 72(2):262-269. DOI: 10.1097/MPG.0000000000002956. View

2.
Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A . Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021; 53(2):156-165. PMC: 8515199. DOI: 10.1038/s41588-020-00763-1. View

3.
Balmant B, Fonseca D, Aguiar Prudencio A, Rocha I, Callado L, Tepedino Martins Alves J . Plasma Zonulin, and Sodium Intake Affect C3 Complement Levels in Inactive Systemic Lupus Erythematosus. Nutrients. 2023; 15(8). PMC: 10144636. DOI: 10.3390/nu15081999. View

4.
Shariati A, Razavi S, Ghaznavi-Rad E, Jahanbin B, Akbari A, Norzaee S . Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study. Infect Agent Cancer. 2021; 16(1):41. PMC: 8191199. DOI: 10.1186/s13027-021-00381-4. View

5.
Poussin C, Sierro N, Boue S, Battey J, Scotti E, Belcastro V . Interrogating the microbiome: experimental and computational considerations in support of study reproducibility. Drug Discov Today. 2018; 23(9):1644-1657. DOI: 10.1016/j.drudis.2018.06.005. View